RESUMO
The aim of this study was to evaluate the effect of fucoxanthin on metabolic syndrome (MetS), insulin sensitivity, and insulin secretion. A randomized, double-blind, placebo-controlled clinical trial was conducted in 28 patients diagnosed with MetS. Patients were randomly assigned to receive 12 mg of fucoxanthin or placebo once a day for 12 weeks. Before and after the intervention, the components of MetS, insulin sensitivity (Matsuda index), first phase of insulin secretion (Stumvoll index), and total insulin secretion were evaluated during a 2-h oral glucose tolerance test. After fucoxanthin administration, significant differences were observed in body weight (BW) (80.6 ± 11.2 vs. 79.16 ± 12.3 kg, P < .01), body mass index (BMI) (31.1 ± 3.6 vs. 30.3 ± 3.7 kg/m2, P < .01), waist circumference (WC) (101.2 ± 9.1 vs. 98.9 ± 9.3 cm, P < .01), systolic blood pressure (SBP) (126.1 ± 10.3 vs. 120.8 ± 9.7 mmHg, P < .01), diastolic blood pressure (DBP) (81.5 ± 6.5 vs. 78.6 ± 6.3 mmHg, P < .01), triglycerides (TG) (2.2 ± 0.7 vs. 2.1 ± 0.7 mmol/L, P < .01), Stumvoll index (2403 ± 621 vs. 2907 ± 732, P < .05), and total insulin secretion (0.84 ± 0.31 vs. 1.02 ± 0.32, P < .05). In conclusion, fucoxanthin administration leads to a decrease in BW, BMI, WC, SBP, DBP, TG, as well as increase in the first phase of insulin secretion and total insulin secretion in patients with MetS. Clinical Trial Registration number: NCT03613740.
Assuntos
Resistência à Insulina , Síndrome Metabólica , Humanos , Síndrome Metabólica/tratamento farmacológico , Síndrome Metabólica/metabolismo , Secreção de Insulina , Insulina/metabolismo , Glicemia/metabolismo , Triglicerídeos , Peso Corporal , Índice de Massa CorporalRESUMO
Phaeodactylum tricornutum is the marine diatom best known for high-value compounds that are useful in aquaculture and food area. In this study, fucoxanthin was first extracted from the diatom using supercritical fluid extraction (SFE) and then using the extracted diatom-like substrate to produce bioenergy through anaerobic digestion (AD) processes. Factors such as temperature (30 °C and 50 °C), pressure (20, 30, and 40 MPa), and ethanol (co-solvent concentration from 10% to 50% v/v) were optimized for improving the yield, purity, and recovery of fucoxanthin extracted using SFE. The highest yield (24.41% w/w) was obtained at 30 MPa, 30 °C, and 30% ethanol but the highest fucoxanthin purity and recovery (85.03mg/g extract and 66.60% w/w, respectively) were obtained at 30 MPa, 30 °C, and 40%ethanol. Furthermore, ethanol as a factor had the most significant effect on the overall process of SFE. Subsequently, P.tricornutum biomass and SFE-extracted diatom were used as substrates for biogas production through AD. The effect of fucoxanthin was studied on the yield of AD, which resulted in 77.15 ± 3.85 LSTP CH4/kg volatile solids (VS) and 56.66 ± 1.90 LSTP CH4/kg VS for the whole diatom and the extracted P.tricornutum, respectively. Therefore, P.tricornutuman can be considered a potential source of fucoxanthin and methane and both productions will contribute to the sustainability of the algae-biorefinery processes.
Assuntos
Biocombustíveis , Diatomáceas/metabolismo , Xantofilas/isolamento & purificação , Anaerobiose/fisiologia , Biomassa , Cromatografia com Fluido Supercrítico/métodos , Etanol/química , Solventes/química , TemperaturaRESUMO
BACKGROUND/AIM: Glioblastomas (GBMs) are the most malignant primary brain tumor. New treatment strategies against the disease are urgently needed, as therapies are not completely efficient. In this study, we evaluated the antitumorigenic activity of the carotenoid fucoxanthin (Fx) on human GBM cells in vitro. MATERIALS AND METHODS: GBM1 cell viability and proliferation was assessed by MTT reduction, Ki67 and single cell cloning assays. GBM1 migration and invasion were analyzed by wound healing and Transwell assays. Apoptosis and necrosis were analyzed by flow cytometry, and the mitochondrial membrane potential (ΔΨm) by the selective fluorescent dye tetramethylrhodamine ethyl ester. Cell morphology was analyzed through scanning electron microscopy and transmission electron microscopy. Fx anti-angiogenic effect was assessed by the CAM ex ovo assay. RESULTS: Fx decreased cell viability in a concentration-dependent manner (40-100 µ M) in GBM1, A172 and C6 cell lines and was not cytotoxic to murine astrocytes. In addition, Fx inhibited the proliferation and clonogenic potential, and decreased migration and invasion of GBM1 cells. Furthermore, Fx induced apoptosis, loss of ΔΨm and ultrastructural alterations in GBM1. Fx-treated GBM1 cells-conditioned medium reduced the quail yolk membrane vascularity. CONCLUSION: Fx induces cytotoxicity, anti-proliferative, anti-invasive and anti-angiogenic effects on GBM1 cells.
Assuntos
Antineoplásicos Fitogênicos/farmacologia , Xantofilas/farmacologia , Animais , Apoptose/efeitos dos fármacos , Linhagem Celular Tumoral , Movimento Celular/efeitos dos fármacos , Proliferação de Células/efeitos dos fármacos , Sobrevivência Celular/efeitos dos fármacos , Meios de Cultivo Condicionados/farmacologia , Relação Dose-Resposta a Droga , Glioblastoma , Humanos , Mitocôndrias/efeitos dos fármacos , Mitocôndrias/metabolismo , Mitocôndrias/ultraestruturaRESUMO
Fucoxanthin possesses a well-described antioxidant activity that might be useful for human skin photoprotection. However, there is a lack of scientific information regarding its properties when applied onto human skin. Thus, the objective of the present study was to assess the photoprotective and phototoxicity potential of fucoxanthin based on its ultraviolet (UVB 280-320 nm; UVA 320-400 nm) and visible (VIS 400-700 nm) absorption, photostability, phototoxicity in 3T3 mouse fibroblast culture vs. full-thickness reconstructed human skin (RHS), and its ability to inhibit reactive oxygen species formation that is induced by UVA on HaCaT keratinocytes. Later, we evaluated the antioxidant properties of the sunscreen formulation plus 0.5% fucoxanthin onto RHS to confirm its bioavailability and antioxidant potential through the skin layers. The compound was isolated from the alga Desmarestia anceps. Fucoxanthin, despite presenting chemical photo-instability (dose 6 J/cm2: 35% UVA and 21% VIS absorbance reduction), showed acceptable photodegradation (dose 27.5 J/cm2: 5.8% UVB and 12.5% UVA absorbance reduction) when it was added to a sunscreen at 0.5% (w/v). In addition, it increased by 72% of the total sunscreen UV absorption spectra, presenting UV-booster properties. Fucoxanthin presented phototoxic potential in 3T3 fibroblasts (mean photo effect 0.917), but it was non-phototoxic in the RHS model due to barrier function that was provided by the stratum corneum. In addition, it showed a significant inhibition of ROS formation at 0.01% (p < 0.001), in HaCat, and in a sunscreen at 0.5% (w/v) (p < 0.001), in RHS. In conclusion, in vitro results showed fucoxanthin protective potential to the skin that might contribute to improving the photoprotective potential of sunscreens in vivo.
RESUMO
Lipid nanoparticles (LNs) are traditional systems able to effectively increase skin hydration. However, due to its reduced viscosity, LNs suspensions are less attractive for skin administration. To overcome this disadvantage, the LN were incorporated in the semi-solid formulation is easy manipulation. This study demonstrated that it is possible to obtain novel LN-loaded fucoxanthin (LN-FUCO) for topical administration containing a combination of bacuri butter and tucumã oil prepared by high shear homogenization for improved stability. The particle size was found to be 243.0 nm and the entrapment efficiency up to 98% of FUCO was incorporated and achieved the suitability of formula. The LN-FUCO hydrogel characteristics of slight acidity, drug content near 100%, and nanometric mean size assure to this formulation high compatibility to dermal application. Photostability assay by UVA, LN-FUCO, and LN-FUCO hydrogel improved photostability and conferred greater protection against FUCO degradation. The results obtained from in vitro skin permeation studies presented a significant difference between LN-FUCO hydrogel and FUCO (p < 0.05), with no detection of the drug in the receptor medium. Therefore, high shear homogenization is demonstrated to be a simple, available, and effective method to prepare high-quality LN-FUCO hydrogel for topical application.
Assuntos
Lipídeos/química , Nanopartículas , Xantofilas/química , Administração Cutânea , Animais , Portadores de Fármacos/metabolismo , Sistemas de Liberação de Medicamentos , Hidrogéis/metabolismo , Tamanho da Partícula , Absorção CutâneaRESUMO
Fucoxanthin (FUCO) is a marine carotenoid characterized by antiproliferative properties against hyperproliferative cells. The aim of this work was to design and develop nanostructured lipidic carriers (NLCs) based on bacuri butter and tucumã oil and loaded with FUCO, intended for skin application to prevent skin hyperproliferative diseases and in particular psoriasis. The presence of FUCO should control the hyperproliferation of skin diseased cells and the lipids forming the NLC core, rich in antioxidants and characterized by wound healing properties, should favor the restoring of skin integrity. NLCs were coated with chitosan (CS) to improve their biopharmaceutical properties (bio/mucoadhesion and wound healing) and to combine the advantages of lipidic nanoparticles with the biological properties of CS. Chitosan coated and non-coated NLC were prepared by means of high shear homogenization and characterized for chemico-physical and biopharmaceutical properties (in vitro biocompatibility and cell uptake towards normal dermal human fibroblasts). Moreover, the pharmacological activity of FUCO loaded in NLCs was assessed in psoriatic-like cellular model. NLCs were characterized by dimensions ranging from about 250 to 400â¯nm. Moreover, the CS coating and FUCO loading determined an increase of size. Moreover, TEM and zeta potential analysis confirmed the presence of CS coating on nanoparticle surface, thus conferring to nanoparticle good bioadhesion properties. NLCs uptake in fibroblasts was observed and NLC-FUCO-CS caused a reduction of cell viability with a less marked effect in fibroblasts rather than in psoriatic cells, highlighting the capability of this system to control skin hyperproliferation and inflammation. The loading of NLC-FUCO-CS in pullulan film should render NLCs application easy, without impair prompt interaction of the drug with the skin. Considering the overall results skin application of CS coated NLCs loaded with FUCO seems a promising approach to control skin hyperproliferation and to preserve skin integrity in psoriatic skin.
Assuntos
Quitosana/administração & dosagem , Portadores de Fármacos/administração & dosagem , Nanoestruturas/administração & dosagem , Xantofilas/administração & dosagem , Administração Cutânea , Linhagem Celular , Sobrevivência Celular/efeitos dos fármacos , Fibroblastos/metabolismo , Humanos , Lipídeos/administração & dosagem , Psoríase/tratamento farmacológicoRESUMO
Fucoxanthin is a major carotenoid found in marine brown algae. This study investigated the impact of fucoxanthin on the growth performance, antioxidant metabolism and meat quality of broilers. Overall, 180 one-day-old male broiler chicks (Ross 308) were assigned to one control group (CONT) and 2 treatment groups (FUCO1 and FUCO2), with six replicates of 10 birds each. The CONT, FUCO1 and FUCO2 birds were fed a basal diet supplemented with 0, 100 and 200 mg/kg of fucoxanthin, respectively. Average body weight gain (BWG), feed intake (FI) and feed conversion ratio (FCR) were similar among the groups. Fucoxanthin increased catalase (CAT) and superoxide dismutase (SOD) activities and glutathione (GSH) levels (p 0.01), and reduced malondialdehyde (MDA) levels (p 0.01) in the liver, breast and drumstick tissues. The effects of fucoxanthin on drumstick yellowness (b*) on day 3 and water activity (aw) on day 5 and breast lightness (L*) on day 3 b* values days 2 and 5 were limited and variable. While fucoxanthin showed antimicrobial effect against Staphylococcus spp. in the breast meat on days 5 and 6 of storage (p 0.05), its effects at different time periods and against other microorganisms varied. In conclusion, fucoxanthin did not affect performance parameters, but had a significant impact on antioxidant metabolism, and showed a limited effect on the microbial quality of meat.(AU)
Assuntos
Animais , Carotenoides/administração & dosagem , Galinhas , Antioxidantes , Carne , Aumento de Peso , Anti-Infecciosos/análise , Phaeophyceae , Staphylococcus , Ração AnimalRESUMO
Turbinaria deccurrens Bory contains bioactive compound that is beneficial for health. Turbinaria deccurrens Bory is one of many species of brown seaweed that grows in Indonesian marine life and has been known to have cytotoxic activity. The aim of this study is to determine fucoxantin content and the cytotoxic activity of extract and fraction T. decurrens on colon cancer cell lines. Cytotoxic assay of ethanolic extract, n-hexane, ethyl acetate and ethanolic fractions against HCT-116 by MTS assay using Cell Counting Kit-8 (CCK-8). Fucoxantin content in extract and fraction were analyzed using Reversed-Phase High Performance Liquid Chromatography (RP-HPLC) analysis. Extract and fraction of T. decurrens contain fucoxanthin with the highest content of fucoxanthin was in ethyl acetate fraction. CCK-8 assay showed that extract, n-hexane and ethyl acetate fraction inhibited the growth of HCT-116. Brown seaweed Turbinaria decurrens was potential as an anticolon cancer agent.
Turbinaria deccurrens Bory contiene compuestos bioactivos que son beneficiosos para la salud. Turbinaria deccurrens Bory es una de muchas especies de algas pardas que crecen en aguas marinas de Indonesia y se ha estudiado su actividad citotóxica. El objetivo de este estudio fue determinar el contenido de fucoxantina y la actividad citotóxica del extracto y la fracción de T. decurrens en líneas celulares de cáncer de colon. Se llevó a cabo un ensayo citotóxico de extracto etanólico, nhexano, acetato de etilo y fracciones etanólicas contra HCT-116 mediante ensayo MTS utilizando Cell Counting Kit-8 (CCK-8). El contenido de fucoxantina en el extracto y la fracción se analizaron usando cromatografía líquida de alta resolución de fase reversa (RP-HPLC). El extracto y la fracción de T. decurrens contienen fucoxantina conmayor contenido de fucoxantina en la fracción de acetato de etilo. El ensayo CCK-8 mostró que la fracción de extracto, n-hexano y acetato de etilo inhibía el crecimiento de HCT-116. El alga marrón Turbinaria decurrens es un agente potencial contra el cáncer de colon.
Assuntos
Extratos Vegetais/administração & dosagem , Neoplasias do Colo/tratamento farmacológico , Xantofilas/administração & dosagem , Células HCT116/efeitos dos fármacos , Phaeophyceae , Extratos Vegetais/química , Xantofilas/análise , Linhagem Celular Tumoral/efeitos dos fármacosRESUMO
Fucoxanthin is a major carotenoid found in marine brown algae. This study investigated the impact of fucoxanthin on the growth performance, antioxidant metabolism and meat quality of broilers. Overall, 180 one-day-old male broiler chicks (Ross 308) were assigned to one control group (CONT) and 2 treatment groups (FUCO1 and FUCO2), with six replicates of 10 birds each. The CONT, FUCO1 and FUCO2 birds were fed a basal diet supplemented with 0, 100 and 200 mg/kg of fucoxanthin, respectively. Average body weight gain (BWG), feed intake (FI) and feed conversion ratio (FCR) were similar among the groups. Fucoxanthin increased catalase (CAT) and superoxide dismutase (SOD) activities and glutathione (GSH) levels (p 0.01), and reduced malondialdehyde (MDA) levels (p 0.01) in the liver, breast and drumstick tissues. The effects of fucoxanthin on drumstick yellowness (b*) on day 3 and water activity (aw) on day 5 and breast lightness (L*) on day 3 b* values days 2 and 5 were limited and variable. While fucoxanthin showed antimicrobial effect against Staphylococcus spp. in the breast meat on days 5 and 6 of storage (p 0.05), its effects at different time periods and against other microorganisms varied. In conclusion, fucoxanthin did not affect performance parameters, but had a significant impact on antioxidant metabolism, and showed a limited effect on the microbial quality of meat.
Assuntos
Animais , Anti-Infecciosos/análise , Antioxidantes , Aumento de Peso , Carne , Carotenoides/administração & dosagem , Galinhas , Phaeophyceae , Ração Animal , StaphylococcusRESUMO
ABSTRACT Fucoxanthin is a major carotenoid found in marine brown algae. This study investigated the impact of fucoxanthin on the growth performance, antioxidant metabolism and meat quality of broilers. Overall, 180 one-day-old male broiler chicks (Ross 308) were assigned to one control group (CONT) and 2 treatment groups (FUCO1 and FUCO2), with six replicates of 10 birds each. The CONT, FUCO1 and FUCO2 birds were fed a basal diet supplemented with 0, 100 and 200 mg/kg of fucoxanthin, respectively. Average body weight gain (BWG), feed intake (FI) and feed conversion ratio (FCR) were similar among the groups. Fucoxanthin increased catalase (CAT) and superoxide dismutase (SOD) activities and glutathione (GSH) levels (p 0.01), and reduced malondialdehyde (MDA) levels (p 0.01) in the liver, breast and drumstick tissues. The effects of fucoxanthin on drumstick yellowness (b*) on day 3 and water activity (aw) on day 5 and breast lightness (L*) on day 3 b* values days 2 and 5 were limited and variable. While fucoxanthin showed antimicrobial effect against Staphylococcus spp. in the breast meat on days 5 and 6 of storage (p 0.05), its effects at different time periods and against other microorganisms varied. In conclusion, fucoxanthin did not affect performance parameters, but had a significant impact on antioxidant metabolism, and showed a limited effect on the microbial quality of meat.
RESUMO
Brown algae and its carotenoids have been shown to have a positive influence on obesity and its comorbidities. This study evaluated the effect of Undaria pinnatifida and fucoxanthin on biochemical, physiological and inflammation markers related to obesity and on the expression of genes engaged on white adipose tissue lipid metabolism in a murine model of diet-induced obesity. The treatments improved energy expenditure, ß-oxidation and adipogenesis by upregulating PPARα, PGC1α, PPARγ and UCP-1. Adipogenesis was also confirmed by image analysis of the retroperitoneal adipose tissue, by measuring cell area, perimeter and cellular density. Additionally, the treatments, ameliorated adipose tissue accumulation, insulin resistance, blood pressure, cholesterol and triglycerides concentration in serum, and reduced lipogenesis and inflammation by downregulating acetyl-CoA carboxylase (ACC) gene expression, increasing serum concentration and expression of adiponectin as well as downregulating IL-6 expression. Both fucoxanthin and Undaria pinnatifida may be considered for treating obesity and other diseases related.